NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Anti-Infectives Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Anti-Infectives Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Aspergillosis



Abelcet prolongs survival and reduces organ fungal load in CNS aspergillosis



December 12th, 2005

Abelcet significantly prolongs survival and reduced organ fungal load in central nervous system aspergillosis.

"Currently, few options exist to treat central nervous system (CNS) aspergillosis, which is usually fatal. We tested the efficacy of Abelcet and caspofungin, alone and in combination for treatment of this disease. Male CD-1 mice were immunosuppressed with 200 mg/kg cyclophosphamide 2 days prior to infection and every 5 days thereafter," investigators in the United States report.

"In the first study, mice were infected intracerebrally with 2.1x106 conidia/mouse of Aspergillus fumigatus; 10 days of once daily therapy began...


Source: Anti-Infectives Week (2005-12-12)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login